Touchstone International Medical Science Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -15.35% vs 9.30% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -26.52% vs 15.79% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "55.70",
          "val2": "65.80",
          "chgp": "-15.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.00",
          "val2": "12.00",
          "chgp": "-58.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "1.10",
          "chgp": "-90.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9.70",
          "val2": "13.20",
          "chgp": "-26.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "89.80%",
          "val2": "136.60%",
          "chgp": "-4.68%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 7.51% vs 9.30% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 9.73% vs 9.49% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "270.40",
          "val2": "251.50",
          "chgp": "7.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "56.70",
          "val2": "41.50",
          "chgp": "36.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.20",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.90",
          "val2": "4.10",
          "chgp": "-146.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "51.90",
          "val2": "47.30",
          "chgp": "9.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "170.20%",
          "val2": "125.90%",
          "chgp": "4.43%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

55.70

65.80

-15.35%

Operating Profit (PBDIT) excl Other Income

5.00

12.00

-58.33%

Interest

0.20

0.00

Exceptional Items

0.10

1.10

-90.91%

Consolidate Net Profit

9.70

13.20

-26.52%

Operating Profit Margin (Excl OI)

89.80%

136.60%

-4.68%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -15.35% vs 9.30% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -26.52% vs 15.79% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

270.40

251.50

7.51%

Operating Profit (PBDIT) excl Other Income

56.70

41.50

36.63%

Interest

0.40

0.20

100.00%

Exceptional Items

-1.90

4.10

-146.34%

Consolidate Net Profit

51.90

47.30

9.73%

Operating Profit Margin (Excl OI)

170.20%

125.90%

4.43%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 7.51% vs 9.30% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 9.73% vs 9.49% in Dec 2023

All Annual Results